The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction.

Genuardi MV, Mather PJ. The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction. Ther Adv Cardiovasc Dis. 2021 Jan-Dec; 15:17539447211002678.

View in: PubMed